ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013

IOM Panel Suggest Ways To Fund More Training, Construction

November 9, 1990

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013

Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook

June 19, 1992

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013